Prevalence and control of type 2 diabetes mellitus among primary care physicians in Spain. PRISMA Study

Endocrinología, Diabetes Y Nutrición
Josep Franch-NadalJordi Sarroca

Abstract

To describe the prevalence of known and ignored type 2 diabetes mellitus (T2DM) among primary care physicians (PCP), as well as the treatment used and the degree of metabolic control reached. Descriptive cross-sectional study on national level. The participants were randomly selected PCPs, members of the redGDPS Foundation. A total of 495 PCP were enrolled. Capillary HbA1c measurement was done with a A1CNow+® device and a diabetes-related survey specifically designed for the study was administered to the participants. The total prevalence of T2DM was 11.1% (95% CI 8.33-13.9) (known disease 8,1% and ignored disease 3.0%). The prevalence of prediabetes was 16.2% (95% CI 13.0-19.4). A total of 62.5% of PCPs with known T2DM reached HbA1c<7% and 15% had HbA1c>8.5%. Control of blood pressure (BP<140/90mmHg) was reached in 87.5% and control of LDL cholesterol<130mg/dl with no history of cardiovascular disease was reached in 88.6% of cases of known T2DM. In the PCPs with a history of macrovascular disease, good control of LDL was reached in 42.9% of the cases. A total of 12.5% were active smokers. A total of 71.4% of PCPs with known T2DM self-treated their own disease, usually with 2 or more drugs (51.4%). The most commonly used drug w...Continue Reading

References

Feb 6, 2004·JAMA : the Journal of the American Medical Association·Erica Frank
Jan 2, 2008·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·Michele HeislerRodney A Hayward
Dec 15, 2010·The Journal of the Royal College of Physicians of Edinburgh·E B Oberg, E Frank
Jul 15, 2011·Medicina clínica·José Ramón BanegasUNKNOWN en representación de los investigadores del Estudio CHABS
Dec 27, 2011·Medicina clínica·Carlos Catalina RomeroLuis Miguel Ruilope Urioste
Mar 27, 2012·The Diabetes Educator·Antoinette M SchoenthalerWalter F Stewart
Nov 30, 2013·The European Journal of General Practice·Nataly LernerShlomo Vinker
Dec 21, 2013·Diabetes Care·UNKNOWN American Diabetes Association
Jun 24, 2014·Atherosclerosis·M CabreraUNKNOWN ICARIA (Ibermutuamur CArdiovascular RIsk Assesment) Study Group
Nov 20, 2014·Journal of Diabetes and Metabolic Disorders·Tahereh KeramatiBagher Larijani

❮ Previous
Next ❯

Citations

May 1, 2021·International Journal of Environmental Research and Public Health·Carmen Valdés Y LlorcaMercedes Rizo Baeza
Jun 3, 2021·International Journal of Environmental Research and Public Health·Jessica Ruiz-ToledoElena de Planell-Mas
May 26, 2021·Atencion primaria·Francisco J Cuevas FernándezMiguel Ángel García Bello

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.

Cardiovascular Disorder in Diabetes

Diabetes is associated with an increased risk of cardiovascular disorders and heart failure. Discover the latest research here.

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

© 2022 Meta ULC. All rights reserved